{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:18:49Z","timestamp":1793060329154,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01988-y","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:33:45Z","timestamp":1761122025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Managing post-bariatric hypoglycemia: a systematic review of pharmacological therapies"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-6503","authenticated-orcid":false,"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri","family":"Sivaramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"1","key":"1988_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","volume":"33","author":"D Eisenberg","year":"2023","unstructured":"Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, de Luca M, Faria SL, Goodpaster KPS, Haddad A, Himpens JM, Kow L, Kurian M, Loi K, Mahawar K, Nimeri A, O\u2019Kane M, Papasavas PK, Ponce J, Pratt JSA, Rogers AM, Steele KE, Suter M, Kothari SN. 2022 American society of metabolic and bariatric surgery (ASMBS) and international federation for the surgery of obesity and metabolic disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33(1):3\u201314.","journal-title":"Obes Surg"},{"key":"1988_CR2","unstructured":"International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). 5th IFSO Global Registry Report [monograph on the Internet]. Naples, Italy: IFSO. 2019. Available from: https:\/\/www.ifso.com\/pdf\/5th-ifso-global-registry-report-september-2019.pdf (Accessed on 18 May 2025)."},{"issue":"1","key":"1988_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11695-018-3525-0","volume":"29","author":"PE O\u2019Brien","year":"2019","unstructured":"O\u2019Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3\u201314.","journal-title":"Obes Surg"},{"issue":"1","key":"1988_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.soard.2015.04.011","volume":"12","author":"NR Obeid","year":"2016","unstructured":"Obeid NR, Malick W, Concors SJ, Fielding GA, Kurian MS, Ren-Fielding CJ. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis. 2016;12(1):11\u201320.","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"1988_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3122\/jabfm.2024.240335R1","volume":"38","author":"HM Lawler","year":"2025","unstructured":"Lawler HM, McGinnis T, Patti ME. Diagnosis and management of post-bariatric hypoglycemia. J Am Board Fam Med. 2025;38(2):383\u201394.","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"1988_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.numecd.2021.08.047","volume":"32","author":"R Lupoli","year":"2022","unstructured":"Lupoli R, Lembo E, Rainone C, et al. Rate of post-bariatric hypoglycemia using continuous glucose monitoring: a meta-analysis of literature studies. Nutr Metab Cardiovasc Dis. 2022;32(1):32\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"1988_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3949\/ccjm.92a.24033","volume":"92","author":"A Iqbal","year":"2025","unstructured":"Iqbal A, Makin V. Hypoglycemia after bariatric surgery: management updates. Cleve Clin J Med. 2025;92(2):103\u20138.","journal-title":"Cleve Clin J Med"},{"issue":"13","key":"1988_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134295","volume":"12","author":"AM Ramos-Levi","year":"2023","unstructured":"Ramos-Levi AM, Rubio-Herrera MA, Mat\u00eda-Mart\u00edn P, P\u00e9rez-Ferre N, Marcuello C, S\u00e1nchez-Pernaute A, et al. Mixed meal tolerance test versus continuous glucose monitoring for an effective diagnosis of persistent post-bariatric hypoglycemia. J Clin Med. 2023;12(13):4295.","journal-title":"J Clin Med"},{"key":"1988_CR9","unstructured":"Desimone ME, Weinstock RS, Hypoglycemia. [Updated 2018 May 5]. In: Feingold KR, Ahmed SF, Anawalt B, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2000. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279137\/ (Accessed on 18 May 2025)."},{"issue":"3","key":"1988_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.soard.2016.12.005","volume":"13","author":"D Eisenberg","year":"2017","unstructured":"Eisenberg D, Azagury DE, Ghiassi S, Grover BT, Kim JJ. ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery. Surg Obes Relat Dis. 2017;13(3):371\u20138.","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"1988_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/njs.NJS_24_17","volume":"24","author":"P Sethi","year":"2018","unstructured":"Sethi P, Thillai M, Nain PS, Ahuja A, Aulakh N, Khurana P. Role of hunger hormone Ghrelin in long-term weight loss following laparoscopic sleeve gastrectomy. Niger J Surg. 2018;24(2):121\u20134.","journal-title":"Niger J Surg"},{"key":"1988_CR12","unstructured":"Athavale A, Ganipisetti VM. Postbariatric Surgery Hypoglycemia. [Updated 2023 Aug 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK592417\/ (Accessed on May 18, 2025)."},{"key":"1988_CR13","doi-asserted-by":"crossref","unstructured":"Looi EJ, Lawler HM. Outpatient treatment of postbariatric hypoglycemia with Canagliflozin. AACE endocrinology and diabetes. 2025.","DOI":"10.1016\/j.aed.2025.03.008"},{"key":"1988_CR14","unstructured":"Proposal for systematic review for drug interventions for treating post-bariatric hypoglycemia. Available at: https:\/\/osf.io\/f8ha9 (accessed on 18th April 2025)."},{"key":"1988_CR15","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: Assessing risk of bias in a randomized trial [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024. Available from cochrane.org\/handbook (accessed on 27th April 2025)."},{"issue":"1","key":"1988_CR16","volume":"7","author":"LL Ma","year":"2020","unstructured":"Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7.","journal-title":"Mil Med Res"},{"key":"1988_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111537","volume":"176","author":"ID Florez","year":"2024","unstructured":"Florez ID, De La Cruz-Mena JE, Veroniki AA. Network meta-analysis: a powerful tool for clinicians, decision-makers, and methodologists. J Clin Epidemiol. 2024;176:111537.","journal-title":"J Clin Epidemiol"},{"key":"1988_CR18","unstructured":"EpiGear International. Available at: https:\/\/www.epigear.com\/index.htm (Accessed on 6 May 2025)."},{"key":"1988_CR19","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"issue":"9","key":"1988_CR20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed). 2021;74(9):790\u20139.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"1988_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-19-0171","volume":"181","author":"KE Almby","year":"2019","unstructured":"Almby KE, Abrahamsson N, Lundqvist MH, Hammar U, Thombare K, Panagiotou A, et al. Effects of GLP-1 on counter-regulatory responses during hypoglycemia after GBP surgery. Eur J Endocrinol. 2019;181(2):161\u201371.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1988_CR22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41366-023-01368-4","volume":"47","author":"C Coelho","year":"2023","unstructured":"Coelho C, Dobbie LJ, Crane J, Douiri A, Learoyd AE, Okolo O, et al. Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial. Int J Obes (Lond). 2023;47(11):1132\u201342.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"1988_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/dom.14920","volume":"25","author":"LJM de Heide","year":"2023","unstructured":"de Heide LJM, Wouda SHT, Peters VJT, Oosterwerff-Suiker M, Gerdes VA, Emous M, et al. Medical and surgical treatment of postbariatric hypoglycaemia: retrospective data from daily practice. Diabetes Obes Metab. 2023;25(3):735\u201347.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1988_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cmet.2020.02.013","volume":"31","author":"M Hepprich","year":"2020","unstructured":"Hepprich M, Wiedemann SJ, Schelker BL, Trinh B, St\u00e4rkle A, Geigges M, L\u00f6liger J, B\u00f6ni-Schnetzler M, Rudofsky G, Donath MY. Postprandial hypoglycemia in patients after gastric bypass surgery is mediated by Glucose-Induced IL-1\u03b2. Cell Metab. 2020;31(4):699\u2013e7095.","journal-title":"Cell Metab"},{"issue":"3","key":"1988_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/osp4.409","volume":"6","author":"SR Kashyap","year":"2020","unstructured":"Kashyap SR, Kheniser K, Aminian A, Schauer P, Le Roux C, Burguera B. Double-blinded, randomized, and controlled study on the effects of Canagliflozin after bariatric surgery: a pilot study. Obes Sci Pract. 2020;6(3):255\u201363.","journal-title":"Obes Sci Pract"},{"issue":"6","key":"1988_CR26","doi-asserted-by":"publisher","first-page":"E956","DOI":"10.1152\/ajpendo.00023.2020","volume":"318","author":"C Martinussen","year":"2020","unstructured":"Martinussen C, Veedfald S, Dirksen C, Bojsen-M\u00f8ller KN, Svane MS, Wewer Albrechtsen NJ, van Hall G, Kristiansen VB, Fenger M, Holst JJ, Madsbad S. The effect of acute dual SGLT1\/SGLT2 Inhibition on incretin release and glucose metabolism after gastric bypass surgery. Am J Physiol Endocrinol Metab. 2020;318(6):E956\u201364.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"1988_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S2213-8587(19)30157-3","volume":"7","author":"AD Miras","year":"2019","unstructured":"Miras AD, P\u00e9rez-Pevida B, Aldhwayan M, Kamocka A, McGlone ER, Al-Najim W, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(7):549\u201359.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1988_CR28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamasurg.2023.2930","volume":"158","author":"J Mok","year":"2023","unstructured":"Mok J, Adeleke MO, Brown A, Magee CG, Firman C, Makahamadze C, Jassil FC, Marvasti P, Carnemolla A, Devalia K, Fakih N, Elkalaawy M, Pucci A, Jenkinson A, Adamo M, Omar RZ, Batterham RL, Makaronidis J. Safety and efficacy of Liraglutide, 3.0\u00a0mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial. JAMA Surg. 2023;158(10):1003\u201311.","journal-title":"JAMA Surg"},{"issue":"4","key":"1988_CR29","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1210\/clinem\/dgz197","volume":"105","author":"CM Mulla","year":"2020","unstructured":"Mulla CM, Zavitsanou S, Laguna Sanz AJ, Pober D, Richardson L, Walcott P, et al. A randomized, placebo-controlled double-blind trial of a closed-loop glucagon system for postbariatric hypoglycemia. J Clin Endocrinol Metab. 2020;105(4):e1260-71.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1988_CR30","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.2337\/dc21-2252","volume":"45","author":"CK Nielsen","year":"2022","unstructured":"Nielsen CK, \u00d8hrstr\u00f8m CC, Kielgast UL, Hansen DL, Hartmann B, Holst JJ, Lund A, Vilsb\u00f8ll T, Knop FK. Dasiglucagon effectively mitigates postbariatric postprandial hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, crossover trial. Diabetes Care. 2022;45(6):1476\u201381.","journal-title":"Diabetes Care"},{"issue":"12","key":"1988_CR31","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.2337\/dc23-1193","volume":"46","author":"CK Nielsen","year":"2023","unstructured":"Nielsen CK, \u00d8hrstr\u00f8m CC, Houji IJK, Helsted MM, Krogh LSL, Johansen NJ, Hartmann B, Holst JJ, Vilsb\u00f8ll T, Knop FK. Dasiglucagon treatment for postprandial hypoglycemia after gastric bypass: A Randomized, Double-Blind, Placebo-Controlled trial. Diabetes Care. 2023;46(12):2208\u201317.","journal-title":"Diabetes Care"},{"issue":"9","key":"1988_CR32","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/dom.13796","volume":"21","author":"CC \u00d8hrstr\u00f8m","year":"2019","unstructured":"\u00d8hrstr\u00f8m CC, Worm D, H\u00f8jager A, Andersen D, Holst JJ, Kielgast UL, et al. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide. Diabetes Obes Metab. 2019;21(9):2142\u201351.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1988_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.soard.2020.08.037","volume":"17","author":"CC \u00d8hrstr\u00f8m","year":"2021","unstructured":"\u00d8hrstr\u00f8m CC, Hansen DL, Kielgast UL, Bergmann ML, Veedfald S, Holst JJ, et al. Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2021;17(1):55\u201363.","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"1988_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000515598","volume":"14","author":"A Ciudin","year":"2021","unstructured":"Ciudin A, S\u00e1nchez M, Hernandez I, Cordero E, Fidilio E, Comas M, Gonzalez C, Lopez N, Vilallonga R, Giralt M, Ferrer R, Hern\u00e1ndez C, Sim\u00f3 R. Canagliflozin: A new therapeutic option in patients that present postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: A pilot study. Obes Facts. 2021;14(3):291\u20137.","journal-title":"Obes Facts"},{"issue":"10","key":"1988_CR35","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.soard.2016.02.013","volume":"12","author":"JJ Gorgojo-Mart\u00ednez","year":"2016","unstructured":"Gorgojo-Mart\u00ednez JJ, Feo-Ortega G, Serrano-Moreno C. Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery. Surg Obes Relat Dis. 2016;12(10):1856\u201363.","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"1988_CR36","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s11695-019-04248-x","volume":"30","author":"CC \u00d8hrstr\u00f8m","year":"2020","unstructured":"\u00d8hrstr\u00f8m CC, Hansen DL, Kielgast UL, Hartmann B, Holst JJ, Worm D. A low dose of Pasireotide prevents hypoglycemia in Roux-en-Y gastric bypass-operated individuals. Obes Surg. 2020;30(4):1605\u201310.","journal-title":"Obes Surg"},{"issue":"8","key":"1988_CR37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1089\/dia.2011.0302","volume":"14","author":"P Ritz","year":"2012","unstructured":"Ritz P, Vaurs C, Bertrand M, Anduze Y, Guillaume E, Hanaire H. Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring. Diabetes Technol Ther. 2012;14(8):736\u201340.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"1988_CR38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s11695-011-0581-0","volume":"22","author":"JP Valderas","year":"2012","unstructured":"Valderas JP, Ahuad J, Rubio L, Escalona M, Pollak F, Maiz A. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels. Obes Surg. 2012;22(4):582\u20136.","journal-title":"Obes Surg"},{"issue":"6","key":"1988_CR39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1530\/EJE-13-0504","volume":"169","author":"N Abrahamsson","year":"2013","unstructured":"Abrahamsson N, Engstr\u00f6m BE, Sundbom M, Karlsson FA. GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication? Eur J Endocrinol. 2013;169(6):885\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1988_CR40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1210\/js.2019-00097","volume":"3","author":"A Ames","year":"2019","unstructured":"Ames A, Lago-Hernandez CA, Grunvald E. Hypoglycemia after gastric bypass successfully treated with calcium channel blockers: two case reports. J Endocr Soc. 2019;3(7):1417\u201322.","journal-title":"J Endocr Soc"},{"key":"1988_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1193696","volume":"14","author":"G Bellastella","year":"2023","unstructured":"Bellastella G, Caruso P, Carbone C, di Nuzzo M, Scappaticcio L, Paglionico VA, et al. Case report: post-gastrectomy reactive hyperinsulinemic hypoglicaemia: glucose trends before and after Canagliflozin treatment. Front Endocrinol (Lausanne). 2023;14:1193696.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"1988_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006348","volume":"96","author":"S Chiappetta","year":"2017","unstructured":"Chiappetta S, Stier C. A case report: liraglutide as a novel treatment option in late dumping syndrome. Medicine (Baltimore). 2017;96(12):e6348.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1988_CR43","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.soard.2013.11.006","volume":"10","author":"LJ de Heide","year":"2014","unstructured":"de Heide LJ, Laskewitz AJ, Apers JA. Treatment of severe postRYGB hyperinsulinemic hypoglycemia with pasireotide: a comparison with octreotide on insulin, glucagon, and GLP-1. Surg Obes Relat Dis. 2014;10(3):e31-3.","journal-title":"Surg Obes Relat Dis"},{"key":"1988_CR44","doi-asserted-by":"publisher","unstructured":"Fiore A, Gaetano S, Ausilia L, Federica S, Giulia S, Damiano G. Efficacy of semaglutide in reactive hypoglycemia related to dumping syndrome after bariatric surgery. Endocr Metab Immune Disord Drug Targets. 2024;22. https:\/\/doi.org\/10.2174\/0118715303318399240715065513.","DOI":"10.2174\/0118715303318399240715065513"},{"issue":"1","key":"1988_CR45","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.soard.2011.05.010","volume":"9","author":"A Gonzalez-Gonzalez","year":"2013","unstructured":"Gonzalez-Gonzalez A, Delgado M, Fraga-Fuentes MD. Use of diazoxide in management of severe postprandial hypoglycemia in patient after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(1):e18-9.","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"1988_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4158\/EP09110.CRR","volume":"16","author":"N Guseva","year":"2010","unstructured":"Guseva N, Phillips D, Mordes JP. Successful treatment of persistent hyperinsulinemic hypoglycemia with nifedipine in an adult patient. Endocr Pract. 2010;16(1):107\u201311.","journal-title":"Endocr Pract"},{"issue":"9","key":"1988_CR47","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/oby.2010.15","volume":"18","author":"F Halperin","year":"2010","unstructured":"Halperin F, Patti ME, Goldfine AB. Glucagon treatment for post-gastric bypass hypoglycemia. Obesity. 2010;18(9):1858\u201360.","journal-title":"Obesity"},{"issue":"1","key":"1988_CR48","doi-asserted-by":"publisher","first-page":"e262428","DOI":"10.1136\/bcr-2024-262428","volume":"18","author":"B Jiang","year":"2025","unstructured":"Jiang B, Malone A, Schmiedel O. Management of severe post-bariatric hypoglycaemia with octreotide delivered via a tandem t:slim insulin pump. BMJ Case Rep. 2025;18(1):e262428.","journal-title":"BMJ Case Rep"},{"issue":"9","key":"1988_CR49","first-page":"e69037","volume":"16","author":"T Mazhude","year":"2024","unstructured":"Mazhude T, Zahra T, September 09. Refractory hyperinsulinemic hypoglycemia as a complication of Roux-en-Y gastric bypass surgery. Cureus. 2024;16(9):e69037.","journal-title":"Cureus"},{"issue":"3","key":"1988_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4158\/EP14118.OR","volume":"21","author":"JP Mordes","year":"2015","unstructured":"Mordes JP, Alonso LC, Evaluation. Medical Therapy, and course of adult persistent hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass surgery: A case series. Endocr Pract. 2015;21(3):237\u201346.","journal-title":"Endocr Pract"},{"issue":"12","key":"1988_CR51","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s11695-008-9569-9","volume":"18","author":"RO Moreira","year":"2008","unstructured":"Moreira RO, Moreira RB, Machado NA, Gon\u00e7alves TB, Coutinho WF. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg. 2008;18(12):1618\u201321.","journal-title":"Obes Surg"},{"issue":"9","key":"1988_CR52","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s11695-009-9888-5","volume":"19","author":"E Spanakis","year":"2009","unstructured":"Spanakis E, Gragnoli C. Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg. 2009;19(9):1333\u20134.","journal-title":"Obes Surg"},{"issue":"11","key":"1988_CR53","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luae194","volume":"2","author":"E Stortz","year":"2024","unstructured":"Stortz E, Lawler H. Tirzepatide improves early dumping syndrome and glucose nadir in postbariatric hypoglycemia after sleeve gastrectomy. JCEM Case Reports. 2024;2(11):luae194.","journal-title":"JCEM Case Reports"},{"issue":"7","key":"1988_CR54","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","volume":"17","author":"J Ram\u00edrez","year":"2018","unstructured":"Ram\u00edrez J, Ca\u00f1ete JD. Anakinra for the treatment of rheumatoid arthritis: a safety evaluation. Expert Opin Drug Saf. 2018;17(7):727\u201332.","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"1988_CR55","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110(6):851\u201360.","journal-title":"J Clin Invest"},{"issue":"3","key":"1988_CR56","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ni.3659","volume":"18","author":"E Dror","year":"2017","unstructured":"Dror E, Dalmas E, Meier DT, Wueest S, Th\u00e9venet J, Thienel C, Timper K, Nordmann TM, Traub S, Schulze F, Item F, Vallois D, Pattou F, Kerr-Conte J, Lavallard V, Berney T, Thorens B, Konrad D, B\u00f6ni-Schnetzler M, Donath MY. Postprandial macrophage-derived IL-1\u03b2 stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol. 2017;18(3):283\u201392.","journal-title":"Nat Immunol"},{"issue":"10","key":"1988_CR57","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/oby.20829","volume":"22","author":"NQ Nguyen","year":"2014","unstructured":"Nguyen NQ, Debreceni TL, Bambrick JE, Chia B, Deane AM, Wittert G, et al. Upregulation of intestinal glucose transporters after Roux-en-Y gastric bypass to prevent carbohydrate malabsorption. Obesity. 2014;22(10):2164\u201371.","journal-title":"Obesity"},{"issue":"3","key":"1988_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.cmet.2016.01.018","volume":"23","author":"G Baud","year":"2016","unstructured":"Baud G, Daoudi M, Hubert T, Raverdy V, Pigeyre M, Hervieux E, et al. Bile diversion in Roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake. Cell Metab. 2016;23(3):547\u201353.","journal-title":"Cell Metab"},{"issue":"3","key":"1988_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14030210","volume":"14","author":"P Evenepoel","year":"2022","unstructured":"Evenepoel P, Meijers B, Masereeuw R, Lowenstein J. Effects of an SGLT inhibitor on the production, toxicity, and elimination of gut-derived uremic toxins: a call for additional evidence. Toxins (Basel). 2022;14(3):210.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"1988_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/oby.23600","volume":"31","author":"DC Llewellyn","year":"2023","unstructured":"Llewellyn DC, Logan Ellis H, Aylwin SJB, O\u0161tarija\u0161 E, Green S, Sheridan W, et al. The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review. Obesity. 2023;31(1):20\u201330.","journal-title":"Obesity"},{"issue":"14","key":"1988_CR61","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003272","volume":"95","author":"V Schwetz","year":"2016","unstructured":"Schwetz V, Horvath K, Kump P, Lackner C, Perren A, Forrer F, et al. Successful medical treatment of adult nesidioblastosis with Pasireotide over 3 years: a case report. Medicine. 2016;95(14):e3272.","journal-title":"Medicine"},{"issue":"3","key":"1988_CR62","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11154-022-09710-3","volume":"23","author":"M Bolanowski","year":"2022","unstructured":"Bolanowski M, Ka\u0142u\u017cny M, Witek P, Jawiarczyk-Przyby\u0142owska A. Pasireotide-a novel somatostatin receptor ligand after 20 years of use. Rev Endocr Metab Disord. 2022;23(3):601\u201320.","journal-title":"Rev Endocr Metab Disord"},{"key":"1988_CR63","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2213-8587(14)70169-X","volume":"2","author":"MR Gadelha","year":"2014","unstructured":"Gadelha MR, Bronstein MD, Brue T, et al. Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. Lancet Diabetes Endocrinol. 2014;2:875\u201384.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1988_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2015-000327","volume":"2","author":"JJ DiNicolantonio","year":"2015","unstructured":"DiNicolantonio JJ, Bhutani J, O\u2019Keefe JH. Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open Heart. 2015;2(1):e000327.","journal-title":"Open Heart"},{"key":"1988_CR65","unstructured":"McIver LA, Preuss CV, Tripp J. Acarbose. [Updated 2024 Feb 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493214\/."},{"key":"1988_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/DMSO.S20633","volume":"4","author":"N Kedia","year":"2011","unstructured":"Kedia N. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes. 2011;4:337\u201346.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1988_CR67","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dc17-1402","volume":"41","author":"U H\u00f6velmann","year":"2018","unstructured":"H\u00f6velmann U, Bysted BV, Mouritzen U, et al. Pharmacokinetic and pharmacodynamic characteristics of dasiglucagon, a novel soluble and stable glucagon analog. Diabetes Care. 2018;41:531\u20137.","journal-title":"Diabetes Care"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01988-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:06:55Z","timestamp":1761124015000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01988-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01988-y","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out on a publicly available database due to which Ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}